Aktienanalyse zu MetLife Inc (MET)METMetLife Inc

MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets. It operates in the Financials sector (LIFE INSURANCE industry).

MetLife Inc (MET) is a good buy right now due to its current price of $96.51, which is below the average analyst price target of $108. Additionally, the stock has shown a year-to-date change of +20.16%, reflecting strong performance. However, the main risk is the high debt-to-equity ratio of 146.04%, indicating potential leverage concerns.

16 analysts cover MET: 9 rate it Buy, 6 Hold and 1 Sell. The average price target is 95.25.